- ANGLE has been granted a Chinese patent and an Australian patent for its Parsortix system, which captures rare cells in blood for medical analysis.

The patents provide protection over a wide range of uses of the Parsortix technology. Granted patents have already been secured in the United States.

Corresponding patent applications have been made worldwide in countries considered to represent substantial markets for Parsortix products. The company is pursuing a strategy to strengthen the breadth and duration of its patent coverage across major markets worldwide to maximise the commercial returns that can be achieved from its Parsortix technology.

New patent applications will continue to be made in all territories consistent with this strategy.

At 8:07am: [LON:AGL] ANGLE PLC share price was +2.5p at 103.5p

Story provided by